Esophageal cancer surgery: Difference between revisions

Jump to navigation Jump to search
Line 53: Line 53:


===Radiotherapy===
===Radiotherapy===
[[Radiotherapy]] is given before, during or after [[chemotherapy]] or [[surgery]], and sometimes on its own to control symptoms. In patients with localized disease but contraindications to surgery, "radical radiotherapy" may be used with curative intent.
[[Radiotherapy]] is given before, during or after [[chemotherapy]] or [[surgery]], and sometimes on its own to control symptoms. In patients with localized disease but contraindications to surgery, "radical radiotherapy" may be used with curative intent.<ref name="pmid2032882">{{cite journal |vauthors=Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M |title=Tolerance of normal tissue to therapeutic irradiation |journal=Int. J. Radiat. Oncol. Biol. Phys. |volume=21 |issue=1 |pages=109–22 |year=1991 |pmid=2032882 |doi= |url=}}</ref><ref name="pmid13432180">{{cite journal |vauthors=SEAMAN WB, ACKERMAN LV |title=The effect of radiation on the esophagus; a clinical and histologic study of the effects produced by the betatron |journal=Radiology |volume=68 |issue=4 |pages=534–41 |year=1957 |pmid=13432180 |doi=10.1148/68.4.534 |url=}}</ref>


==References==
==References==

Revision as of 14:51, 7 December 2017

Esophageal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Esophageal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal cancer surgery On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophageal cancer surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal cancer surgery

CDC on Esophageal cancer surgery

Esophageal cancer surgery in the news

Blogs on Esophageal cancer surgery

Directions to Hospitals Treating Esophageal cancer

Risk calculators and risk factors for Esophageal cancer surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]Hadeel Maksoud M.D.[3]

Overview

The predominant therapy for esophageal cancer is surgical resection. Adjunctive chemotherapy and radiation may be required.

Surgery

Stage 0 Esophageal Cancer

Stage 0 squamous esophageal cancer is rarely seen in the United States, but surgery has been used for this stage of cancer[1]

Stage I Esophageal Cancer

Standard treatment options:

  • Chemoradiation with subsequent surgery
  • Surgery

Stage II Esophageal Cancer

Standard treatment options:

  • Chemoradiation with subsequent surgery
  • Chemoradiation alone
  • Surgery alone

Stage III Esophageal Cancer

Standard treatment options:

  • Chemoradiation with subsequent surgery
  • Chemoradiation alone

Stage IV Esophageal Cancer

At diagnosis, approximately 50% of patients with esophageal cancer will have metastatic disease and will be candidates for palliative therapy.

Standard treatment options:

  • Chemoradiation with subsequent surgery (for patients with stage IVA disease)
  • Endoscopic-placed stents to provide palliation of dysphagia
  • Radiation therapy with or without intraluminal intubation and dilation
  • Intraluminal brachytherapy to provide palliation of dysphagia
  • Nd:YAG endoluminal tumor destruction or electrocoagulation
  • Chemotherapy has provided partial responses for patients with metastatic distal esophageal adenocarcinoma[2]

Stenting

If the patient cannot swallow at all, a stent may be inserted to keep the esophagus patent; stents may also assist in occluding fistulas. A nasogastric tube may be necessary to continue feeding while treatment for the tumor is given, and some patients require a gastrostomy (feeding hole in the skin that gives direct access to the stomach). The latter two are especially important if the patient tends to aspirate food or saliva into the airways, predisposing for aspiration pneumonia.

Esophageal stent for esophageal cancer by James Heilman, MD - Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=49111485

Esophagectomy

The disease must be localised in order for it to be operable, which is the case in 20-30% of patients. If a tumor is particularly large but still localised, it may be shrunk down first using chemotherapy and/or radiotherapy until the tumor becomes of a size that is operable. Removing a segment of the esophagus is called an esophagectomy. The procedure shortens the distance between the pharynx and the stomach. The stomach, or some other part of the gastrointestinal tract, such as the colon, is brought up into the chest cavity where it is interposed. [3]

The optimal surgical procedure is controversial. One approach promotes the transhiatal esophagectomy with anastomosis of the stomach to the cervical esophagus technique. A second approach advocates abdominal mobilization of the stomach and transthoracic excision of the esophagus with anastomosis of the stomach to the upper thoracic esophagus or the cervical esophagus.[4] [5]

Laser therapy

Laser therapy is described as the use of a high intensity beam of light to destroy malignant cells; it affects only the area it is focussed on whilst unharming the healthy cells. This is done when tumors are inoperable because of their size, location and/or spread. Sometimes, the aim is palliation, so that the patient may have some of the symptoms of dysphagia and pain relieved. Photodynamic therapy (PDT), a type of laser therapy, involves the use of drugs that are absorbed by cancer cells; when exposed to a particular wave length of light, the drugs become active and destroy the tumor cells.[6][7]

Radiotherapy

Radiotherapy is given before, during or after chemotherapy or surgery, and sometimes on its own to control symptoms. In patients with localized disease but contraindications to surgery, "radical radiotherapy" may be used with curative intent.[8][9]

References

  1. Affleck DG, Karwande SV, Bull DA, Haller JR, Stringham JC, Davis RK (2000). "Functional outcome and survival after pharyngolaryngoesophagectomy for cancer". Am. J. Surg. 180 (6): 546–50. PMID 11182415.
  2. "Esophageal Cancer Treatment".
  3. Deschamps C, Nichols FC, Cassivi SD; et al. (2005). "Long-term function and quality of life after esophageal resection for cancer and Barrett's". Surgical Clinics of North America. 85 (3): 649–656. PMID 15927658.
  4. Triboulet JP, Mariette C, Chevalier D, Amrouni H (2001). "Surgical management of carcinoma of the hypopharynx and cervical esophagus: analysis of 209 cases". Arch Surg. 136 (10): 1164–70. PMID 11585510.
  5. Wang HW, Chu PY, Kuo KT, Yang CH, Chang SY, Hsu WH, Wang LS (2006). "A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction". J Surg Oncol. 93 (6): 468–76. doi:10.1002/jso.20472. PMID 16615159.
  6. Haddad NG, Fleischer DE (1994). "Endoscopic laser therapy for esophageal cancer". Gastrointest. Endosc. Clin. N. Am. 4 (4): 863–74. PMID 7529119.
  7. Mellow MH, Pinkas H (1985). "Endoscopic laser therapy for malignancies affecting the esophagus and gastroesophageal junction. Analysis of technical and functional efficacy". Arch. Intern. Med. 145 (8): 1443–6. PMID 4026476.
  8. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M (1991). "Tolerance of normal tissue to therapeutic irradiation". Int. J. Radiat. Oncol. Biol. Phys. 21 (1): 109–22. PMID 2032882.
  9. SEAMAN WB, ACKERMAN LV (1957). "The effect of radiation on the esophagus; a clinical and histologic study of the effects produced by the betatron". Radiology. 68 (4): 534–41. doi:10.1148/68.4.534. PMID 13432180.


Template:WikiDoc Sources